SCHEMBL1625848

SCHEMBL1625848

CCS(=O)(=O)Nc1ncccc1CNc1nc(Nc2cccc(C(=O)NCc3ccccn3)c2)ncc1C(F)(F)F

nearest known ligand 0.76

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTK2 Q05397 20/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14931450 0.92 PTK2 (0.76) PTK2
SCHEMBL1627142 0.92 PTK2 (0.75) PTK2
SCHEMBL14931420 0.90 PTK2 (0.74) PTK2
SCHEMBL14931437 0.89 PTK2 (0.76) PTK2
SCHEMBL14931508 0.88 PTK2 (0.64) PTK2
SCHEMBL14931452 0.88 PTK2 (0.79) PTK2
SCHEMBL14931234 0.87 PTK2 (0.75) PTK2
SCHEMBL14931293 0.87 PTK2 (0.77) PTK2
SCHEMBL29853669 0.86 PTK2 (1.00) PTK2
SCHEMBL1625849 0.86 PTK2 (1.00) PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8440822-B2 Sulfonyl amide derivatives for the treatment of abnormal cell growth PFIZER, INC. 2013-05-14 US disclosed
US-7928109-B2 focal adhesion kinase inhibitor, i.e. FAK inhibitor; tyrosine kinase inhibitors; cancer, osteoporosis; e.g. N-methyl-4-({4-[({3-[methyl(methylsulfonyl)amino]pyrazin-2-yl}methyl)amino]-5-(trifluoromethyl)pyrimidin-2-yl}amino)benzamide hydrochloride PFIZER INC (US) 2011-04-19 US disclosed